News

benzinga_article
2025.12.11 14:01
Kazia Therapeutics shares are trading higher after the company announced new data from two presentations at the 2025 San Antonio Breast Cancer Symposium supporting the activity of paxalisib across both HER2-positive metastatic breast cancer and triple-negative breast cancer.
Source: benzinga_article The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer